Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133931) titled 'Multicenter Retrospective Analysis of EBV Antibodies Detected via Chemiluminescence for Early Auxiliary Diagnosis of Nasopharyngeal Carcinoma' on Oct. 9.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: The Second Affiliated Hospital of Guangxi Medical University

Condition: Nasopharyngeal carcinoma (NPC)

Intervention: Control Group (Healthy Control Group, HC):None

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2026-06-01

Target Sample Size: Control Group (Healthy Control Group, HC):150;Case group (Nasopharyngeal carcinoma, NPC):150;

Countries o...